National

CannPrisma signs an exclusive contract with the Polish company Cosma Cannabis

Published

9 months ago

December 31, 2022

Photo: DR | CannPrisma

A Cannprisma-Pharma, a Portuguese medical cannabis company based in Castro Marim, Algarve, signed an exclusive contract with the Polish company Cosma-Cannabis for the distribution of premium quality medical cannabis in Poland. The two companies seek fruitful cooperation not only in the field of drug distribution, but also in Research and Development (R&D) projects.

Cosma Cannabis will register several CannPrisma cannabis flower cultivars in Poland and hopes to add quality cannabis extracts and tinctures premium to your portfolio in the near future.

Asked by Cannareporter about whether CannPrisma products will also be available in Portugal, the company's CEO, João Nascimento, said that "not yet", because before that they need to obtain GMP certification. “We intend to submit an ACM (Marketing Authorization) in the last quarter of 2023. We haven't done it yet because we need to obtain EU-GMP certification before we have the necessary authorization to place products on the market”, he explained. João Nascimento also told Cannareporter that Cannprisma produced, in 2022, “an approximate amount of 1.100 kg of cannabis flower”.

João Nascimento, CEO of CannPrisma. Photo: Laura Ramos | cannareporter

With regard to the partnership with Cosma, Nascimento said: “We are excited about this milestone, as it represents the opportunity to provide Polish patients with access to high-quality cannabis-based medicines and fulfill our most important mission: to improve health and the well-being of patients around the world", announced João Nascimento, CEO of CannPrisma, in a press release and in a video published on company channel on youtube. “The partnership is the result of effort, transparency and social responsibility between the two companies that combine synergies following a strict code of ethics with the mutual objective of meeting patient needs with safe cannabis-based solutions and continuing to drive the industry forward”, refers to the statement.

Poland has around 38 million inhabitants and 11 registered medical cannabis products. CannPrisma points out that the potential for growth of medical cannabis in Poland “is great and the expected market value is between 40 and 50% of the German market”.